Tuesday, April 19, 2022

SciClone Pharma tests hepatitis drug as Covid-19 vaccine enhancer – ET HealthWorld

China’s SciClone Pharmaceuticals has begun a clinical trial to test if its hepatitis B treatment Zadaxin helps to boost immunity provided by Covid-19 vaccines, it said on Monday.

SciClone said it is using an inactivated Covid-19 vaccine in its trial but did not specify which one. Three coronavirus vaccines approved in China use inactivated virus and have been developed by China National Pharmaceutical Group (Sinopharm) and Sinovac Biotech.

“In view of the mechanism of action of Thymalfasin (Zadaxin) and previous clinical studies, the combination with Thymalfasin may help increase the level of SAR-Cov-2 neutralizing antibody and prolong the antibody protection time,” it said in a statement.

The company plans to recruit 200 trial participants across China and evaluate the safety and ability to elicit immune responses from the vaccine when combined with Zadaxin.

It said the drug has been approved as a vaccine enhancer for the treatment of patients with chronic hepatitis B and immune impairment.

Follow and connect with us on , Facebook, Linkedin

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...